Avicenna Hair

Scarring alopecia and hair transplantation: assessment before restoration

Published October 4, 2026

Updated October 20, 2026

Medically reviewed by Dr. Yaşar Nursoy, MD

Reviewed October 20, 2026

Before hair transplantation is considered for scarring alopecia, a specialist needs to establish the exact cause, assess disease activity and decide whether restoration is reasonable in that particular condition. An inflammatory disorder that destroys follicles is different from a healed scar after an injury or operation. A quiet-looking area or a fixed waiting period cannot, by itself, guarantee a durable transplant result. The British Association of Dermatologists warns that lichen planopilaris can recur at a surgical site even after stabilisation. BAD: lichen planopilaris

The first priority is often protecting remaining hair and managing the disease. Cosmetic restoration may become a later discussion for selected patients. Keeping those goals separate helps prevent a technically possible procedure from being mistaken for treatment of the underlying condition.

What “scarring” means in this context

Scarring alopecia, also called cicatricial alopecia, includes conditions in which follicles are destroyed and replaced by scar tissue. Once a follicle has been destroyed, treatment cannot simply make that same follicle resume growing. In lichen planopilaris, for example, treatment aims to preserve remaining hair and control symptoms. BAD: understanding lichen planopilaris

Several diagnoses fall within the wider group. Frontal fibrosing alopecia can affect the hairline and eyebrows; central centrifugal cicatricial alopecia is another condition requiring specialist assessment. These names should not be treated as interchangeable labels for a shiny patch. Their diagnosis and management depend on the clinical findings. AAD: frontal fibrosing alopecia AAD: central centrifugal cicatricial alopecia

If you have been told only that you have “scar tissue,” ask for the diagnosis in writing. It is useful to know whether this describes the result of a known injury, an established inflammatory disease or an appearance still awaiting investigation.

A person with a scar from a past operation may ask whether hair can camouflage the area. A person with inflammatory scarring alopecia also needs an answer about the condition that caused follicle loss and whether it remains active. Evidence from one group cannot automatically be transferred to the other.

IssueInflammatory scarring alopeciaScar after injury or surgery
Main question about causeWhich disease caused follicle destruction?What event caused the scar, and is its history clear?
Main question before restorationIs the condition adequately assessed and controlled?Are the scar and surrounding tissues suitable for reconstruction?
Evidence to requestOutcomes in the same disease, with meaningful follow-upOutcomes in comparable scars and locations
Important limitationFurther disease activity may threaten hairScar characteristics can affect the technical result

The distinction is supported by research that treats primary and secondary cicatricial alopecia as separate categories. A prospective study of 50 transplant patients was predominantly secondary scarring, with many moustache-area cases; its results should not be presented as a success estimate for inflammatory scalp disease. Madura and colleagues: cicatricial alopecia transplant outcomes

How the specialist assesses the problem

Assessment may include the distribution of loss, scalp symptoms, medical history, medication use and examination of other affected areas. A scalp biopsy may be needed to clarify the diagnosis or identify overlapping causes. In frontal fibrosing alopecia, the AAD describes examination of the hairline, scalp and eyebrows and the possible role of biopsy. AAD: diagnosing frontal fibrosing alopecia

Bring previous biopsy reports, clinical photographs and treatment summaries. If you have had more than one opinion, provide each report. A new clinician should be able to see what was actually found, rather than reconstruct the diagnosis from a brief message such as “my scalp was inflamed.”

Explain changes since the last review. These may include a different area of loss, symptoms or a changed response to treatment. Do not assume an old report automatically describes the current situation. Ask which parts of the assessment remain relevant and whether anything needs updating before restoration is discussed.

What disease control means for the decision

For inflammatory scarring conditions, the aim of treatment may include slowing or stopping further loss and relieving symptoms. The AAD emphasises early treatment for CCCA and frontal fibrosing alopecia because preventing additional loss matters. AAD: CCCA treatment goals AAD: FFA stabilisation

A report that symptoms have improved is useful, but ask how the treating specialist is judging overall control. What examination findings are being followed? Are photographs or measurements being compared? What uncertainty remains? Those questions help you understand the clinical meaning of “stable” without trying to assign yourself that label.

There is no waiting-time guarantee in this guide. If a clinician proposes a period of observation, ask why it is appropriate for your diagnosis and what will be reviewed during it. Time is part of a history; the eventual decision still needs an individual assessment.

What transplant evidence can and cannot promise

Published studies show that restoration has been attempted in selected patients with scarring disorders, but the evidence needs careful reading. A small study of eyebrow transplantation in ten patients with frontal fibrosing alopecia reported encouraging early growth followed by loss of transplanted hair in most patients during longer follow-up. This was an eyebrow study in a particular disease, not a general result for all scalp transplants. Study: eyebrow transplantation in FFA

That example illustrates why an early photograph cannot establish durability. When reviewing evidence, ask how long patients were followed, which diagnosis they had, whether treatment continued and how success was defined. Hair growth, cosmetic satisfaction and disease control are different outcomes.

A study of postsurgical scalp scars is also a different population from patients with an active inflammatory process. Such research may help a surgeon discuss scar reconstruction, but it cannot answer whether a specific inflammatory disease will recur. Study: transplantation into postsurgical scalp scars

Be cautious when a clinic gives one success percentage for “scar transplants” without explaining the underlying conditions. Ask for the closest relevant evidence and an honest account of what remains unknown. Individual uncertainty should remain visible beside any proposed benefit.

Questions that make a restoration discussion more useful

If a specialist considers transplantation reasonable, the conversation should go beyond whether grafts can be inserted. Ask:

  • What is the exact diagnosis, and what supports the assessment of current activity?
  • Which clinician is responsible for managing the underlying disease?
  • What outcomes have been reported in patients with this same condition and treatment history?
  • What are the limits of the donor supply and the proposed recipient area?
  • Is the proposal staged, and what would determine whether a later stage proceeds?
  • How would suspected recurrence be assessed and managed?
  • What would count as a satisfactory outcome from my perspective and from the clinician’s?

These questions are not a request for certainty that medicine cannot provide. They ask the team to make its reasoning visible. A cautious recommendation can still be helpful when it explains the trade-offs clearly.

Keep medical follow-up separate from the travel package

If you are considering care in Istanbul, arrange review of the diagnosis before committing to a surgical trip. Ask whether the clinician assessing restoration has the relevant reports and whether further examination is required. Clarify what happens if the in-person assessment does not support surgery.

Longer-term disease care also needs a practical route after you return home. Identify who will receive updates, review new symptoms and communicate with the surgical team. Keep copies of your records in a language your clinicians can use, with original reports available where possible.

Do not change prescribed treatment to make a procedure fit a travel date. Medication and monitoring decisions belong with the treating clinicians. If their advice conflicts, ask them to resolve the difference before proceeding rather than choosing whichever answer preserves the booking.

A useful outcome may be a clearer sequence of care

Some people will need further diagnostic work. Others may need disease treatment or continued observation before any restoration decision. For some, camouflage or a hairpiece may be preferable to surgery; the BAD includes these among options discussed for lichen planopilaris. BAD: living with lichen planopilaris

The most important distinction is between addressing the disease and addressing its visible aftermath. A restoration procedure does not replace disease management, and a period of control does not erase uncertainty. A well-founded plan explains the diagnosis, the evidence for the next step and the follow-up needed to protect the result and the hair you still have.

Sources and further reading

Medically reviewed by

Dr. Yaşar Nursoy, MD

Physician responsible for hair transplantation

View profile
Last medical review: October 20, 2026

Keep reading

Related guides

Your next step

Questions about your own situation?

General guides cannot assess your case. An individual assessment is the place to discuss suitability and planning.